Multi-cancer Early Detection by means of Cell-free DNA Methylation in Solid Tumors

WEBINAR

November 20 | 16:00 CEST / 15:00 BST

Webinar Description


Early and accurate cancer detection is a critical frontier in oncology. Join us for a deep dive into the cutting-edge field of liquid biopsy research and its application in multi-cancer early detection.

Our distinguished speaker, Smiths S. Lueong (Priv.- Doz. Dr. rer. nat.), a leading expert from the German Cancer Consortium (DKTK) and University Hospital Essen, will illuminate how Cell-Free DNA (cfDNA) Methylation patterns are being leveraged as powerful, non-invasive biomarkers for solid tumors.


Key Takeaways:
  • Understand the biological significance of cfDNA methylation changes in the context of early carcinogenesis and tumor classification.
  • Explore the power of Next-Generation Sequencing (NGS)-based strategies to profile complex epigenetic signatures in liquid biopsy samples.
  • Learn about the current challenges and future directions for translating methylation-based assays from the lab to clinical practice.

Webinar Registration
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.

Speaker

Smiths S. Lueong (Priv.-Doz. Dr. rer. nat.), Senior Scientist
Bridge Institute for Experimental Tumor Therapy West German Cancer Center, Essen University Hospital

Dr. Smiths Lueong studied Biochemistry at the University of Dschang, Cameroon, and completed his Ph.D. in Molecular Biotechnology at the German Cancer Research Center (DKFZ) with a DAAD fellowship. 

He subsequently joined the International Agency for Research on Cancer (IARC, WHO) to study molecular mechanisms of carcinogenesis and biomarkers. He later moved to the German Cancer Consortium (DKTK Essen/Düsseldorf) to focus on liquid biopsies and therapy resistance in solid tumors, where he coordinated the DKTK Liquid Biopsy Working Group and became a member of the German Liquid Biopsy Alliance. 

Dr. Lueong habilitated in Experimental Oncology at the University of Duisburg-Essen and founded the Cameroon Consortium for Translational Cancer Research.

©. All Rights Reserved Twist Bioscience.